Ulixertinib (BVD-523, cat# HY-15816) and
Ruxolitinib (INCB18424, cat# HY-50856) were purchased by MedChemExpress (Monmouth Junction, NJ, USA).
The thrombopoietin mimetic Romiplostim (Nplate
®) was kindly provided by Amgen (Thousand Oaks, CA, USA).
Anti-mouse OPN antibody (cat#BE0373, clone 103D6), the isotype control antibody (cat#BE0366, clone DV5-1) and the
dilution buffer (cat#IP0070) were purchased by Bio X Cell (Lebanon, NH, USA).
Bianchi E., Rontauroli S., Tavernari L., Mirabile M., Pedrazzi F., Genovese E., Sartini S., Dall’Ora M., Grisendi G., Fabbiani L., Maccaferri M., Carretta C., Parenti S., Fantini S., Bartalucci N., Calabresi L., Balliu M., Guglielmelli P., Potenza L., Tagliafico E., Losi L., Dominici M., Luppi M., Vannucchi A.M, & Manfredini R. (2023). Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model. Leukemia, 37(5), 1068-1079.